Cortisol in the Treatment of Phobias

• Status: Completed
• Trial end date: 2009-09-01

Summary

The aim of this prospective, double-blind, placebo-controlled, randomized study is to investigate if glucocorticoid treatment, in combination with exposure therapy, helps to reduce phobic fear in patients with phobia.

• Phase: N/A

Details

• Lead Sponsor: University of Zurich
• Collaborator: University Hospital, Basel, Switzerland
• Treatments: Cortisol succinate; Hydrocortisone; Hydrocortisone 17-butyrate 21-propionate; Hydrocortisone acetate